Published in Cancer Weekly, May 7th, 2002
By identifying the molecular mechanisms that control this failsafe device, it may be possible to design new antiangiogenic drugs or to improve already existing drugs to prevent abnormal blood vessel growth, said Olga Volpert, assistant professor of urology at the Feinberg School and lead author the study, which appeared in the April 2002 issue of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.